Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
Sylvie Négrier(Université Claude Bernard Lyon 1), Christine Lasset(Université Claude Bernard Lyon 1)
Cited by 343
Related Papers
Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
|New England Journal of Medicine|1998|969
Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial
|JNCI Journal of the National Cancer Institute|1999|239
Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group
|Journal of Clinical Oncology|2005|166
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
|European Journal of Cancer|2022|39
Phase II trial of sunitinib in renal cell cancer with untreated brain metastases.
|Journal of Clinical Oncology|2011|7